Schwann cells differentiate in vivo in response to contact with axons, and
cAMP simulates some of these aspects of differentiation in vitro, particula
rly morphologic changes and expression of certain phenotypic molecules. Unf
ractionated inflammatory cytokines inhibit cAMP-induced Schwann cell expres
sion of galactolipids (Gal). We sought to identify which cytokines were res
ponsible for this inhibition and to determine whether other phenotypic indi
cators of Schwann cell differentiation were also affected. Neonatal rat Sch
wann cells were incubated in vitro with 1 mM 8 Bromo cAMP (8 Br cAMP) with
or without the addition of interleukin-1 alpha (IL-1 alpha), IL-1 beta, IL-
2, IL-6, tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gam
ma), or transforming growth factor-beta (TGF-beta). Cells were then examine
d for morphologic changes and for expression of surface Gal and low-affinit
y nerve growth factor receptor (NGFRp75), employing indirect immunofluoresc
ence. 8 Br cAMP induced Schwann cell upregulation of Gal, downregulation of
NGFRp75, and the cells became enlarged and somewhat amorphous and irregula
r in appearance. Cells treated with IFN-gamma or TNF-alpha alone were more
bipolar and more evenly distributed on coverslips than were control cells,
whereas TGF-beta alone induced elongated cells often in a swirling pattern.
None of the cytokines alone induced upregulation of Gal or downregulation
of NGFRp75. TNF-alpha, IFN-gamma, and TGF-beta inhibited the 8 Br cAMP-indu
ced morphologic changes, as well as the upregulation of Gal and downregulat
ion of NGFRp75. The other cytokines had no effects on Gal or NGFRp75 expres
sion. Thus, these three cytokines, which are present in inflammatory lesion
s in the peripheral nervous system, are capable of inhibiting Schwann cell
differentiation. (C) 2001 Wiley-Liss, Inc.